Cleveland Clinic Foundation, Cleveland, OH 44195, USA.
Urology. 2013 Jun;81(6):1123-30. doi: 10.1016/j.urology.2013.01.027. Epub 2013 Mar 19.
Approximately 70%-80% of urothelial carcinomas are detected at the stage of non-muscle-invasive bladder cancer (NMIBC). Initial management is often successful, but recurrence is common and leads to a long, burdensome, costly disease course. The quality and efficiency of care depends in part on accurate, clearly communicated descriptions of tumor characteristics. This review identifies current best practices, unmet needs, and key issues in the pathology of NMIBC for the practicing urologist. Reasonable and objective recommendations are provided with the goal of improving urologist-pathologist communication, the efficiency of healthcare utilization, and outcomes for patients with NMIBC.
大约 70%-80%的尿路上皮癌是在非肌肉浸润性膀胱癌（NMIBC）阶段被发现的。初始治疗通常是成功的，但复发很常见，导致疾病过程漫长、负担沉重且费用高昂。护理的质量和效率部分取决于对肿瘤特征的准确、清晰的描述。本综述确定了当前 NMIBC 病理学的最佳实践、未满足的需求和关键问题，以供临床泌尿科医生参考。提出了合理和客观的建议，目的是改善泌尿科医生与病理学家之间的沟通、医疗保健利用的效率以及 NMIBC 患者的预后。
